Ali Tehrani
2020 - Zymeworks
In 2020, Ali Tehrani earned a total compensation of $4.9M as Former President & CEO at Zymeworks, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $283,653 |
|---|---|
| Option Awards | $3,185,803 |
| Salary | $573,036 |
| Stock Awards | $814,000 |
| Other | $20,967 |
| Total | $4,877,459 |
Tehrani received $3.2M in option awards, accounting for 65% of the total pay in 2020.
Tehrani also received $283.7K in non-equity incentive plan, $573K in salary, $814K in stock awards and $21K in other compensation.
Rankings
In 2020, Ali Tehrani's compensation ranked 2,283rd out of 13,090 executives tracked by ExecPay. In other words, Tehrani earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,283 out of 13,090 | 83rd |
Division Manufacturing | 877 out of 5,621 | 84th |
Major group Chemicals And Allied Products | 314 out of 2,254 | 86th |
Industry group Drugs | 266 out of 1,954 | 86th |
Industry Pharmaceutical Preparations | 190 out of 1,459 | 87th |
Source: SEC filing on November 25, 2022.
Tehrani's colleagues
We found three more compensation records of executives who worked with Ali Tehrani at Zymeworks in 2020.